Beijing Leadman Biochemistry Co Ltd Class A 300289
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥4.31
- Day Range
- ¥4.32–4.57
- 52-Week Range
- ¥3.45–6.74
- Bid/Ask
- ¥4.49 / ¥4.50
- Market Cap
- ¥2.45 Bil
- Volume/Avg
- 9.1 Mil / 5.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 5.48
- Dividend Yield (Trailing)
- 0.22%
- Dividend Yield (Forward)
- 0.22%
- Total Yield
- 0.22%
Company Profile
Beijing Leadman Biochemistry Co Ltd is a biotechnology company based in China. The company is focusing on research and development, manufacture, and sales of in vitro diagnostic (IVD) products. The company has core competencies in biochemistry, in vitro diagnostic reagents and instruments. Its product offering includes biochemical raw materials such as enzymes, coenzymes, antibodies, buffers, and enzyme substrates; biochemistry diagnostic and companion reagents; and medical test instruments.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Core
- Total Number of Employees
- 538
- Website
- http://www.leadmanbio.com
Comparables
Valuation
|
Metric
|
300289
|
688399
|
301060
|
|---|---|---|---|
Price/Earnings (Normalized) | — | — | 29.68 |
Price/Book Value | 1.41 | 1.37 | 2.15 |
Price/Sales | 5.48 | 11.98 | 2.24 |
Price/Cash Flow | 22.72 | 679.36 | 48.96 |
Price/Earnings
300289
688399
301060
Financial Strength
|
Metric
|
300289
|
688399
|
301060
|
|---|---|---|---|
Quick Ratio | 12.83 | 5.79 | 2.66 |
Current Ratio | 14.16 | 6.10 | 3.27 |
Interest Coverage | −19.77 | −45.10 | −9.75 |
Quick Ratio
300289
688399
301060
Profitability
|
Metric
|
300289
|
688399
|
301060
|
|---|---|---|---|
Return on Assets (Normalized) | −0.43% | −8.31% | −4.28% |
Return on Equity (Normalized) | −0.48% | −9.66% | −7.03% |
Return on Invested Capital (Normalized) | −1.02% | −10.10% | −5.26% |
Return on Assets
300289
688399
301060
Medical Devices Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Abbott Laboratories
ABT
| Sjfnfprl | Pjgwjhl | $195.6 Bil | |||
| Stryker Corp
SYK
| Xklvlhlxt | Stkv | $137.3 Bil | |||
| Boston Scientific Corp
BSX
| Blmdkwmkv | Ncbszj | $122.7 Bil | |||
| Medtronic PLC
MDT
| Btgwhxmj | Kbmpjl | $114.6 Bil | |||
| Edwards Lifesciences Corp
EW
| Vzvbtfym | Gzqvxs | $40.1 Bil | |||
| Koninklijke Philips NV ADR
PHG
| Qbw | Zrlj | $30.7 Bil | |||
| DexCom Inc
DXCM
| Cfvjhgpss | Dyhp | $27.0 Bil | |||
| Steris PLC
STE
| Pxvjktylg | Wnzrz | $23.6 Bil | |||
| Zimmer Biomet Holdings Inc
ZBH
| Bkdwldfdw | Vjnp | $22.0 Bil | |||
| Insulet Corp
PODD
| Gpjdnkcfm | Cgvccv | $16.3 Bil |
United States